Program in Neuroinfectious Diseases

Led by Kiran Thakur, MD, the Program in Neuroinfectious Diseases studies neuroinfectious diseases in local, national, and international settings, with a focus on prevention, early diagnosis, and improved outcomes. The Thakur lab conducts patient-centered research aimed at improving the rapid detection of neuroinfectious diseases and reducing the significant morbidity and mortality they cause. 

Dr. Thakur and colleagues, including Kathryn Holroyd, MD, also examine the neurological effects of Human Immunodeficiency Virus (HIV), SARS-CoV-2, and other infectious diseases that can affect the brain and nervous system.

Building on this research, the program team advises public health organizations and conducts implementation studies in partnership with agencies such as the World Health Organization (WHO), the Pan American Health Organization (PAHO), and the Centers for Disease Control and Prevention (CDC).

Mission: To improve the prevention, rapid detection, and treatment of neuroinfectious diseases, helping reduce the serious illness, disability, and loss of life they cause in the United States and around the world.